期刊
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
卷 16, 期 7, 页码 1353-1364出版社
WILEY
DOI: 10.1111/j.1582-4934.2011.01498.x
关键词
myoblast; embryonic stem cell; induced pluripotent stem cell; muscular dystrophy; protocol
资金
- Telethon [GGP09107, GGP10062]
- FIRB [RBFR08RV86]
- Associazione Amici del Centro Dino Ferrari
Muscular dystrophies (MDs) are a heterogeneous group of inherited disorders characterized by progressive muscle wasting and weakness likely associated with exhaustion of muscle regeneration potential. At present, no cures or efficacious treatments are available for these diseases, but cell transplantation could be a potential therapeutic strategy. Transplantation of myoblasts using satellite cells or other myogenic cell populations has been attempted to promote muscle regeneration, based on the hypothesis that the donor cells repopulate the muscle and contribute to its regeneration. Embryonic stem cells (ESCs) and more recently induced pluripotent stem cells (iPSCs) could generate an unlimited source of differentiated cell types, including myogenic cells. Here we review the literature regarding the generation of myogenic cells considering the main techniques employed to date to elicit efficient differentiation of human and murine ESCs or iPSCs into skeletal muscle. We also critically analyse the possibility of using these cellular populations as an alternative source of myogenic cells for cell therapy of MDs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据